Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. AAPL
5. ACN
6. AZN
7. ROIV
8. ORCL
9. HOOD
10. QCOM

Go back to Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Asianada, Inc. (NASDAQ: ASND) Delayed: 269.69 -0.87 (0.32%)
Previous Close $270.56    52 Week High $21.79 
Open $263.41    52 Week Low $11.92 
Day High $272.47    P/E N/A 
Day Low $262.32    EPS $-0.07 
Volume 186,087